Dr. Satyajit Mohapatra

Director

Qualification : MBBS , MD

Experience : 14 years

Speciality : Pharmacology, Clinical Trials

Area of Interest : Pharmacovigilance, Regulatory and investigator initiated clinical trials

Achievements and Awards :

  • Best Researcher Award by Saveetha University, Tamil Nadu for the year 2022.
  • BHARAT RATNA MOTHER TERESA GOLD MEDAL AWARD-2022 by the Global Economic Progress & Research Association (GEPRA) for individual achievement and national development.
  • Received Best researcher award for publication in high impact factor journal- The Lancet—Research Day 2022, SRM IST.
  • Received Best researcher award for major funded project by—Research Day 2022, SRM IST.
  • Received Best researcher award for publication in high impact factor journal- The Lancet Infectious Disease —Research Day 2021, SRM IST.
  • Received Gold medal for best paper in Medical- as co-author for Research Day 2021.
  • Received Silver medal for best paper in Medical- as co-author for Research Day 2017
  • Received Award of appreciation for publication in Teacher’s Day celebration Awards from the Chancellor of SRM University during the academic year 2012-13.
  • Received Award of appreciation for publication in Research Day celebration Awards from the Chancellor of SRM University during the academic year 2013-2014.
  • Speaker at AIIMS Bhopal , AIIMS Guwahati and other national and International conferences.
  • Reviewer for many journals.
  • Academic Editor for Plos One


  • Principal investigator of a mRNA vaccine for Covid-19 in healthy volunteers ( 2021-2022).
  • Principal investigator of A global phase III study of COVID vaccine by Sanofi-GSK (2021-2022)
  • Principal investigator of an inactivated whole cell Virion vaccine in healthy volunteers ( 2020)- The Phase I, Phase II and Phase III clinical trial of BBV152 A (2020-2021).
  • Principal investigator of Booster dose study of BBV152 A (2021-2022)
  • Co-investigator of A Multicenter, Phase III trial of BCG VPM1002 in Serum Institute of India Ltd (2020-2021)
  • Principal investigator of Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine by Sanofi Pasture (2020-2021)
  • Principal investigator of a meningococcal vaccine in a children, adults and elderly population by Sanofi Pasture (2020-2021)
  • Co-investigator of the clinical trial of Sodium copper chlorophyllin on mild asymptomatic COVID patients (2021-2022)
  • Co-investigator of the clinical trial of recombinant BCG on COVID-19 contacts (2020-2021)
  • Co-investigator of the clinical trial of Vit B12 in anemic patients (2020-2021)
  • Co-investigator of the clinical trial of Pregabalin in neuropathic patients (2020-2021)
  • Co-investigator of a BA/BE study on Mupirocin (2020-2021)
  • Co-investigator of the clinical trial of inhalational albuterol in adult asthmatics. (2019-2020)
  • Co-investigator of the clinical trial of inhalational budesonide in adult asthmatics(2019-2020)
  • Principal Investigator of a phase III clinical trial of Pentavalent vaccine- (2019-2020)
  • Co-investigator of a clinical trial of a dermatological study- Acne – (2017-2018)
  • Co-investigator of a clinical trial of Lysostaphin gel in post-surgical wounds- (2017-2018)
  • Principal Investigator of a phase III clinical trial of Quadrivalent vaccine (combination of DTwP-Hib )- (2017-2018)
  • Principal Investigator of a phase III clinical trial of a new formulation of Rotavirus vaccine – (2017- 2018)
  • Principal Investigator of a Phase III clinical trial of a new formulation of Rotavirus vaccine – (2016- 2017)
  • Principal investigator of a phase III clinical trial of Pentavalent vaccine- (2015-2016)
  • Principal Investigator of a completed Phase IV Clinical trial of Rotavirus vaccine with buffering agent- (2014-2015)
  • Co-investigator of the recombinant hepatitis B vaccine in Indian adults- (2008-2009)
  • Principal Investigator of a phase III clinical trial of Quadrivalent vaccine (combination of DTwP-Hib )- (2017-2018).
  • Principal Investigator of a phase III clinical trial of a new formulation of Rotavirus vaccine – (2017- 2018).
  • Principal Investigator of a Phase III clinical trial of a new formulation of Rotavirus vaccine – (2016- 2017)


  • Establishment of Clinical Trial Unit for development of COVID vaccines under Mission Covid Suraksha – funded by BIRAC, Dept. of Biotechnology, Govt. of India. (2021-2022
  • Phase III trial of Covid vaccine in Covid infected individuals- ICMR-
  • Anticov study- DNDi and ICMR.
  • ICMR COVID Vaccine study – 1.1 Crore.


  1. Vadrevu KM, Ganneru B, Reddy S, Jogdand H, Raju D, Sapkal G, Yadav P, Reddy P, Verma
    S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Bhate A, Rai SK, Ella R,
    Abraham P, Prasad S, Ella K. Persistence of immunity and impact of third dose of inactivated
    COVID-19 vaccine against emerging variants. Sci Rep. 2022 Jul 14;12(1):12038.
  2. Mohapatra S, Ananda P, Tripathy S. Pharmacological consideration of COVID-19 infection
    and vaccines in pregnancy. J Chin Med Assoc. 2022 May 1;85(5):537-542
  3. Tripathy S, Murugesan A, Natarajan J, Ramraj B, Mohapatra S. Early screening biomarker
    HbA1c and Hematocrit for gestational diabetes mellitus. Clinical Epidemiology and
    Global Health     2022;13: 100945
  4. Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav
    P, Abraham P, Panda S, Gupta N, Reddy P, Verma S, Kumar Rai S, Singh C, Redkar SV,
    Gillurkar CS, Kushwaha JS, Mohapatra S, et al . Safety and immunogenicity of an inactivated
    SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect
    Dis.     2021 May;21(5):637-646.
  5. Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Raju D, Praturi U,
    Sapkal G, Yadav P, Reddy P, Verma S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS,
    Mohapatra S, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine,
    BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-
    month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021
    Jul;21(7):950-961.
  6. Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, Aileni VK, Kanungo S, Rai S,
    Reddy P, Verma S, Singh C, Redkar S, Mohapatra S, et al ; COVAXIN Study Group. Efficacy,
    safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152):
    interim results of a randomised, double-blind, controlled, phase 3 trial. Lancet. 2021 Dec
    11;398(10317):2173-2184.
  7. Tripathy S, Mohapatra S. Informed Consent for Emergency Obstetric Care During COVID-19
    Pandemic. J Obstet Gynaecol India. 2020 Aug;70(4):275-278.
  8. Mohapatra S, Begum, Srikanth S, Rani J. Knowledge, attitude and the practice (KAP) of
    Pharmacovigilance among health care professionals of a tertiary care teaching hospital of
    South India. Asian Journal of Pharmacy and Pharmacology 2019; 5(4):669-672.
  9. Begum M., Althab, Satyajit Mohapatra, & R. Jamuna Rani. “Adverse drug reactions in
    hospitalized patients in a tertiary care teaching hospital: analysis of the reported cases.
    International Journal of Basic & Clinical Pharmacology [Online], 7.7 (2018): 1377-1381
  10. Upadhy R S S, Tripathy S, Mohapatra S, Prevalence of poly cystic ovarian syndrome among
    students of a tertiary care teaching hospital. Indian J Obstet Gynecol
    Res     2018;5(4):481-484
  11. Raja S, Mohapatra S, Kalaiselvi A, Rani R. J. Awareness and Disposal Practices of Unused
    and Expired Medication Among Health Care Professionals and Students in A Tertiary Care
    Teaching Hospital. Biomed Pharmacol J 2018;11(4).